Toggle Offcanvas
...
 
Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Western Europe Human Drugs Tenders

Bid on readily available Western Europe Human Drugs Tenders with GlobalTenders, the biggest and best online tendering platform, since 2002. Globaltenders.com offers an unmatched database of Human Drugs tenders from Western Europe, more than any other platform.

Daily, new procurement opportunities for Human Drugs are uploaded from thousands of sources including all Western Europe official websites, Western Europe local websites, newspapers and journals. Bidding for Human Drugs tenders in Western Europe is extremely lucrative for companies of all sizes. Western Europe tendering authorities release contracts for most of the Human Drugs products and services procured by them. The most popular categories are -

  • Western Europe human drugs tenders
  • Western Europe human medicine tenders
  • Western Europe generic medicine tenders
Sign up to get instant access to unlimited Western Europe Human Drugs Tenders with advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

2676 Live Notices for Western Europe Human Drugs Tenders

Showing 1 to 20

Substitute Health Insurance Generics No. 22
country Germany
posting date13 Aug 2024
deadline20 Sep 2024
Rapid Drug Tests
country Germany
posting date13 Aug 2024
deadline12 Sep 2024
Carrying Out Health Checks On Private Sector Employees Aged 40 And Over, Health Checks For Managers And Flu Vaccination Campaigns For Volunteer Employees.
country France
posting date13 Aug 2024
deadline16 Sep 2024
Drug Outpatient Clinics
country Germany
posting date13 Aug 2024
deadline09 Sep 2024
Medicines Containing The Active Ingredient Rasagiline (Atc: N04Bd02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Febuxostat (Atc: M04Aa03)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Naproxen (Atc: M01Ae02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Open House Discount Contracts 2024-10
country Germany
posting date13 Aug 2024
deadline30 Sep 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pazopanib (L01Ex03) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Tobramycin (Atc Code: J01Gb01).
country Germany
posting date13 Aug 2024
deadline28 Jul 2026
Bvaeb Framework Agreement On Medicinal Products 2024
country Austria
posting date13 Aug 2024
deadline12 Sep 2024
Medicines Containing The Active Ingredient Dexamethasone (Atc: S01Ba01 - Without Implants)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Substance Sorafenib (Atc: L01Ex02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Telmisartan (Atc: C09Ca07)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Combination Timolol And Latanoprost (Atc: S01Ed61)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen (Atc Code: M01Ae02).
country Germany
posting date13 Aug 2024
deadline28 Jul 2026
Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Aug 2024
deadline03 Aug 2026
Medicines Containing The Active Ingredient Combination Irbesartan And Hydrochlorothiazide (Atc: C09Da24)
country Germany
posting date12 Aug 2024
deadline31 Jul 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pomalidomide (L04Ax06) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Aug 2024
deadline31 Jul 2026
Procurement Of New Equipment For The Areas Of Haematology And Urine Diagnostics For The Westpfalz-Klinikum
country Germany
posting date12 Aug 2024
deadline27 Aug 2024

Share Share this page